-88%

est. 2Y upside i

HealthcareSeed

Rank

#1200

Sector

Mental Wellness / AI

Est. Liquidity

~6Y

Data Quality

Data: Medium

Rosebud is an early-stage AI journaling app with a moderate upside potential, but also a higher risk profile.

Last updated: March 10, 2026

Bull (19%)+400%

Rosebud becomes a leading personalized AI mental wellness platform, expanding beyond journaling into broader self-improvement and coaching. Strong user retention and premium subscription growth, coupled with successful enterprise partnerships, drive ARR to $50M+ by 2028. This justifies a $150M+ valuation (5x current), attracting a strategic acquisition by a larger health tech or consumer tech player.

Base (43%)+75%

Rosebud carves out a niche in the AI journaling market, maintaining steady user growth and subscription revenue. It faces continued competition from larger players but differentiates through its proprietary memory technology and therapist-backed approach. ARR grows to $15-20M by 2028, leading to an acquisition at a modest premium to its current valuation, around $50-60M.

Bear (38%)-80%

Rosebud struggles to scale user acquisition and retention amidst intense competition from well-funded incumbents like Calm and Headspace, and new AI features from big tech. Data privacy concerns or ethical challenges related to AI in mental health also hinder growth. ARR stagnates at $3-5M, leading to a down round or an acquisition at or below its total funding, resulting in minimal or no return for common stock holders.

Est. time to liquidity~6.0 years

Preference Stack Risk

high

Investors hold $6M in liquidation preferences ahead of common stock holders, representing 20% of the estimated current valuation.

Dilution Risk

high

As a seed-stage company, multiple future funding rounds (Series A, B, etc.) are anticipated, which will significantly dilute existing common stock holders.

Secondary Liquidity

none

There are no active secondary markets or tender offers for a company at this early stage.

Other — 16 roles

View all 16 open roles at Rosebud →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Rosebud's data — designed to show you've done your homework.

  • 1

    “How does Rosebud plan to differentiate its 'proprietary memory technology' and 'awareness engine' from the rapidly evolving capabilities of foundational LLMs offered by companies like OpenAI and Anthropic, especially as these models become more accessible and integrated into competitor products?”

  • 2

    “With a current ARR of ~$1M and 7,500+ paying customers, what are the key growth levers and target metrics for scaling to $20M-$50M ARR over the next 2-3 years, particularly considering the competitive landscape and the need for significant team expansion?”

  • 3

    “Given the seed funding round and the estimated preference stack, what is the company's philosophy on future funding rounds and potential liquidity events, and how does it plan to ensure meaningful returns for common stock holders?”

Community

Valuation Sentiment

Our model estimates -88% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.